Coronary/peripheral artery disease planned with catheter intervention
Conditions
Interventions
Patients for staged catheter intervention on coronary and peripheral vessels were administered with 30 IU/kg of initial bolus unfractionated heparin. ACT is tested before and every 30 minutes after in
Sponsors
Nishiarai Heart Center Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients for coronary or peripheral vessel intervention with informed consent, and without predicted demerit on heparin use.
Exclusion criteria
Exclusion criteria: i) Emergent/urgent intervention ii) Patients with malignant neoplasm whose life expectancies of less than 6 months iii) Patients with active bleeding or embolic complications iv) Patients with HIT(Heparin-Induced Thrombocytopenia) v) Unsuitable patients for this trial judged by doctor-in-charge
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| i) Time achieved with ACT>250 seconds ii) Bleeding and embolic complications up to 30 days after the procedure | — |
Secondary
| Measure | Time frame |
|---|---|
| i) Frequency of heparin addition during procedure ii) Change of WBC/RBC/Platelets between before and after the procedure iii) All-cause death, MACE | — |
Countries
Japan
Contacts
Public ContactKentaro Jujo
Nishiarai Heart Center Hospital Department of Cardiology
Outcome results
None listed